Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper

被引：1
|
作者：
Qin, Hong [1 ]
You, Changqiao [1 ]
Yan, Feng [1 ]
Tan, Kefang [1 ]
Xu, Changgen [1 ]
Zhao, Rui [2 ]
Ekpo, Marlene Davis [2 ]
Tan, Songwen [2 ]
机构：
[1] NanHua Biomed CO Ltd, Res & Dev Dept, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
natural killer (NK) cells; immunosenescence; immunotherapy; cancer; chemotherapy; biotherapeutics; CAR-NK CELLS; CORD BLOOD; ADOPTIVE TRANSFER; CYTOKINE RELEASE; IN-VIVO; IMMUNOTHERAPY; ACTIVATION; EXPANSION; THERAPY; TRANSPLANTATION;
D O I：
10.3389/fonc.2022.1062765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
    Margaret G. Lamb
    Hemalatha G. Rangarajan
    Brian P. Tullius
    Dean A. Lee
    Stem Cell Research & Therapy, 12
  • [32] Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
    Philippa R. Kennedy
    Martin Felices
    Jeffrey S. Miller
    Stem Cell Research & Therapy, 13
  • [33] Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
    Kennedy, Philippa R.
    Felices, Martin
    Miller, Jeffrey S.
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [34] Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities
    Bisht, Kamlesh
    Merino, Aimee
    Igarashi, Rob
    Gauthier, Laurent
    Chiron, Marielle
    Desjonqueres, Alexandre
    Smith, Eric
    Briercheck, Edward
    Romee, Rizwan
    Alici, Evren
    Vivier, Eric
    O'Dwyer, Michael
    van de Velde, Helgi
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [35] Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
    Lamb, Margaret G.
    Rangarajan, Hemalatha G.
    Tullius, Brian P.
    Lee, Dean A.
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [36] Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance
    Razmara, Aryana M.
    Judge, Sean J.
    Gingrich, Alicia A.
    Cruz, Sylvia M.
    Culp, William T. N.
    Kent, Michael S.
    Rebhun, Robert B.
    Canter, Robert J.
    FRONTIERS IN VETERINARY SCIENCE, 2021, 8
  • [37] Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges
    Amer, Mahetab H.
    Rose, Felicity R. A. J.
    Shakesheff, Kevin M.
    Modo, Michel
    White, Lisa J.
    NPJ REGENERATIVE MEDICINE, 2017, 2
  • [38] Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges
    Mahetab H. Amer
    Felicity R. A. J. Rose
    Kevin M. Shakesheff
    Michel Modo
    Lisa J. White
    npj Regenerative Medicine, 2
  • [39] T-cell and natural killer cell development in thymectomized Xenopus
    Horton, JD
    Horton, TL
    Dzialo, R
    Gravenor, I
    Minter, R
    Ritchie, P
    Gartland, L
    Watson, MD
    Cooper, MD
    IMMUNOLOGICAL REVIEWS, 1998, 166 : 245 - 258
  • [40] Development of a natural killer (NK) ImmunoGraft platform for the evaluation of the pharmacodynamics of immuno-oncology therapeutics
    Verma, Bhavana
    Ruggeri, Bruce
    Weidanz, Jon
    Wesa, Amy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345